ClinVar Miner

Submissions for variant NM_000251.3(MSH2):c.1812TGT[1] (p.Val606del)

dbSNP: rs267607978
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000491246 SCV000580417 likely pathogenic Hereditary cancer-predisposing syndrome 2019-03-11 criteria provided, single submitter clinical testing The c.1815_1817delTGT variant (also known as p.V606del) is located in coding exon 12 of the MSH2 gene. This variant results from an in-frame TGT deletion between nucleotide positions 1815 and 1817. The valine at codon 606 is deleted. This variant was first identified in a patient who met Bethesda criteria and was diagnosed with endometrial complex atypical hyperplasia (CAH), endometrial adenocarcinoma (EC), and ovarian carcinoma at the age of 50. The patient was also diagnosed with multiple colorectal carcinomas, but the age at each diagnosis was not available. MSI and IHC analysis performed on tumor tissue from CAH and EC showed MSI-H and loss of MSH2 expression with no loss of MLH1 expression (Sutter C et al. Int. J. Gynecol. Pathol. 2004 Jan; 23(1):18-25). This variant was also detected by traditional sequencing techniques as well as SNP genotyping in one patient whose tumor tissue displayed microsatellite instability (Bujalkova M et al. Clin. Chem. 2008 Nov; 54(11):1844-54). The variant is deleterious using an evolution-based in silico predictor, PROVEAN, and this amino acid position is highly conserved in available vertebrate species (Choi Y et al. PLoS ONE 2012;7(10):e46688). Based on internal structural analysis, this variant sits in the lever region of MSH2 and is anticipated to result in a significant decrease in structural stability (Warren JJ et al. Mol. Cell 2007 May; 26(4):579-92 and Mukherjee S et al. Biophys. J. 2009 Mar; 96(5):1707-20). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.